Who
Yekaterina Chudnovsky
Director and 10% owner
Company insider
Files Form 4 as: Director and 10% owner, Elicio Therapeutics; Director and 10% owner, Immix Biopharma.
In numbers
- Trades disclosed
- 19
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 22 Aug 2023
- Last trade
- 31 Aug 2026
- Last filed
- 2 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Aug 2026filed 2 Sep 2026 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,750 at $0.00 | filing |
| 31 Aug 2026filed 2 Sep 2026 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,750 at $0.00 | filing |
| 22 May 2026filed 29 May 2026 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Code A | —6,250 at $0.00 | filing |
| 22 May 2026filed 29 May 2026 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 22 May 2026filed 29 May 2026 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 22 May 2026filed 29 May 2026 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Code A | —6,250 at $0.00 | filing |
| 20 Jun 2025filed 23 Jun 2025 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,000 at $0.00 | filing |
| 3 Jun 2025filed 4 Jun 2025 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —103,225 at $0.00 | filing |
| 19 May 2025filed 20 May 2025 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,900 at $0.00 | filing |
| 5 Mar 2025filed 7 Mar 2025 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | $20.0M3,442,341 at $5.81 | filing |
| 5 Mar 2025filed 7 Mar 2025 | ELTX Elicio TherapeuticsBiotechnology | SEC FORM 4 Code C | $20.3M3,500,573 at $5.81 | filing |
| 21 Nov 2024filed 25 Nov 2024 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,100 at $0.00 | filing |
| 12 Aug 2024filed 14 Aug 2024 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code P | $20.0M3,442,341 at $5.81 | filing |
| 28 Jun 2024filed 2 Jul 2024 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code P | —1,600,000 at $0.00 | filing |
| 28 Jun 2024filed 2 Jul 2024 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code P | $8.0M1,600,000 at $4.99 | filing |
| 11 Jun 2024filed 21 Jun 2024 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,000 at $0.00 | filing |
| 28 Dec 2023filed 29 Dec 2023 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,100 at $0.00 | filing |
| 22 Aug 2023filed 23 Aug 2023 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 22 Aug 2023filed 23 Aug 2023 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,670 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.